UP-REGULATED THROMBOXANE PRODUCTION IN THE RAT LIVER WITH BILIARY OBSTRUCTION DOES NOT CONTRIBUTE TO PROMOTE HEPATIC INJURY

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Shock

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/SHK.0b013e31815812ffPMID 17885643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of thromboxane A2 in early BDL-induced portal hypertension

  2010influential reference
• LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver.

  2007cited by this paper
• INHIBITION OF ENDOTHELIN-1-MEDIATED UP-REGULATION OF INOS BY BOSENTAN AMELIORATES ENDOTOXIN-INDUCED LIVER INJURY IN CIRRHOSIS

  2006cited by this paper
• Role of thromboxane A2 in early BDL-induced portal hypertension.

  2003cited by this paper
• Endothelin 1 Impairs Oxygen Delivery in Livers From LPS-Primed Animals

  2002cited by this paper
• Endothelin Receptor Remodeling Induces the Portal Venous Hyper-Response to Endothelin Following Endotoxin Pretreatment

  2002cited by this paper
• Hemorrhagic shock primes the hepatic portal circulation for the vasoconstrictive effects of endothelin-1.

  2001cited by this paper
• Altered endothelin receptor subtype expression in hepatic injury after ischemia/reperfusion.

  2000cited by this paper
• Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1.

  1999cited by this paper
• Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia.

  1999cited by this paper
• Inhibition of thromboxane A2 synthesis by OKY-046 attenuates ischemia and reperfusion injury of the liver.

  1999cited by this paper
• Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane A2 receptor.

  1999cited by this paper
• Impaired renal function in obstructive jaundice: roles of the thromboxane and endothelin systems.

  1997cited by this paper
• Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats.

  1996cited by this paper
• Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.

  1996cited by this paper
• Response of plasma and tissue endothelin‐1 to liver ischemia and its implication in ischemia‐reperfusion injury

  1995cited by this paper
• Tissue eicosanoids and vascular permeability in rats with chronic biliary obstruction

  1993cited by this paper
• Increased pulmonary vascular permeability in rats with biliary cirrhosis: role of thromboxane A2.

  1993cited by this paper
• A thromboxane A2 synthetase inhibitor, OKY-046, reduces liver damage in hepatectomy.

  1993cited by this paper
• Elevation of plasma endothelin concentrations during endotoxin shock in dogs.

  1991cited by this paper
• Elevation of plasma endothelin concentrations during endotoxin shock in dogs.

  1991cited by this paper
• Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study.

  1989cited by this paper
• Output and effects of thromboxane produced by the liver perfused with phorbol myristate acetate.

  1988cited by this paper
• Effects of leukotrienes and the thromboxane A2 analogue U-46619 in isolated perfused rat liver. Metabolic, hemodynamic and ion-flux responses.

  1988cited by this paper
• Stimulation of glycogenolysis and vasoconstriction in the perfused rat liver by the thromboxane A2 analogue U-46619.

  1987cited by this paper
• Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.

  1987cited by this paper
• Improvement in Organ Blood Flow by Inhibition of Thromboxane Synthetase During Experimental Endotoxic Shock in the Rat

  1986cited by this paper
• Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.

  1982cited by this paper

• The impact of subchronic ozone exposure on serum metabolome and the mechanisms of abnormal bile acid and arachidonic acid metabolisms in the liver.

  2023cites this paper
• The Role of Inflammatory Mediators in Liver Failure

  2011cites this paper
• Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.

  2010cites this paper
• Bile duct ligation in neonatal rats: Is it a valid experimental model for biliary atresia studies?

  2009cites this paper
• What's new in Shock, June 2008?

  2008cites this paper